학술논문

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer
Document Type
article
Source
Cancer Epidemiology Biomarkers & Prevention. 30(9)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Prevention
Human Genome
Cancer
Genetics
Ovarian Cancer
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
Autophagy-Related Protein-1 Homolog
Biomarkers
Tumor
Carcinoma
Ovarian Epithelial
Female
Gene Knockout Techniques
Genome-Wide Association Study
Humans
Intracellular Signaling Peptides and Proteins
Ovarian Neoplasms
Polymorphism
Single Nucleotide
Progression-Free Survival
AGO Study Group
OPAL Study Group
for Australian Ovarian Cancer Study Group
Medical and Health Sciences
Epidemiology
Biomedical and clinical sciences
Health sciences
Language
Abstract
BackgroundMany loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance.MethodsWe carried out a genome-wide association study (GWAS) of PFS in 2,352 women with EOC who had undergone cytoreductive surgery and standard carboplatin/paclitaxel chemotherapy.ResultsWe found seven SNPs at 12q24.33 associated with PFS (P < 5 × 10-8), the top SNP being rs10794418 (HR = 1.24; 95% CI, 1.15-1.34; P = 1.47 × 10-8). High expression of a nearby gene, ULK1, is associated with shorter PFS in EOC, and with poor prognosis in other cancers. SNP rs10794418 is also associated with expression of ULK1 in ovarian tumors, with the allele associated with shorter PFS being associated with higher expression, and chromatin interactions were detected between the ULK1 promoter and associated SNPs in serous and endometrioid EOC cell lines. ULK1 knockout ovarian cancer cell lines showed significantly increased sensitivity to carboplatin in vitro.ConclusionsThe locus at 12q24.33 represents one of the first genome-wide significant loci for survival for any cancer. ULK1 is a plausible candidate for the target of this association.ImpactThis finding provides insight into genetic markers associated with EOC outcome and potential treatment options.See related commentary by Peres and Monteiro, p. 1604.